Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00393848|
Recruitment Status : Completed
First Posted : October 29, 2006
Results First Posted : June 2, 2014
Last Update Posted : June 2, 2014
|Condition or disease||Intervention/treatment||Phase|
|Hip Fracture Osteoarthritis Femur Head Necrosis||Drug: Essential amino acid supplement Drug: Ketoconazole Drug: Placebo||Phase 2|
Hip fractures among the elderly are a major health concern. Nearly one-third of elderly hip fracture patients die within 1 year of the injury. Events surrounding the actual injury and any necessary surgical repair often lead to reduced muscle protein, and eventually, muscle strength. Loss in everyday function and independence may follow, especially in elderly or frail individuals. The decrease in protein synthesis may be caused by two main events following injury and surgery: prolonged inactivity and an increase in stress hormone levels. Preventing a loss in protein may help to improve outcomes for individuals undergoing hip surgery and rehabilitation. The purpose of this study is to determine the effects of two postoperative interventions designed to retain muscle protein after major hip or knee surgery in adults.
This study will include two experiments. Experiment 1 will include individuals who are scheduled for hip or knee replacement surgery because of osteoarthritis (the need to repair or replace the affected joint), or avascular necrosis (bone tissue death caused by lack of blood supply). Experiment 1 participants will be randomly assigned to one of two groups:
- Group 1 participants will receive daily supplements of essential amino acids, which are thought to stimulate protein synthesis.
- Group 2 participants will receive standard rehabilitation care while in the hospital and will serve as controls for the effect of time on recovery.
Participants will be in the hospital for about 4 days. On the morning of surgery, blood and urine collection will occur. During surgery, substances called tracers, measuring the extent of protein synthesis and breakdown, will be injected into a vein for the first metabolic study. Additional blood and muscle samples will also be taken. After surgery, when participants arrive in the surgical recovery unit and are able to eat, they will begin to record all food intake and will receive their assigned treatment. Treatment, in the form of gel capsules, will be taken 2.5 hours after each meal. Urine will be collected throughout hospitalization and blood will be collected each morning. Prior to discharge, a 24-hour metabolic study will be performed, including tracer injections and muscle biopsies. After discharge, participants will be provided with 6 weeks' worth of their assigned treatment. Follow-up visits will occur 2 and ~6 to 8 weeks after surgery. These visits will include various muscle function and physical performance tests. Participants will also undergo a dual energy x-ray absorptiometry (DEXA) scan, which will be used to determine muscle mass.
Experiment 2 participants will include individuals scheduled for either hip or knee replacement surgery or fracture repair surgery. Participants will be randomly assigned to one of two groups:
- Group 1 participants will receive the antifungal drug ketoconazole, which is thought to reduce levels of the stress hormone cortisol.
- Group 2 participants will receive placebo and standard rehabilitation care while in the hospital.
Participants will begin taking their assigned treatments the day prior to surgery; those with a hip fracture will take their assigned treatment at least 4 hours prior to surgery. The same procedures that occurred in Experiment 1 during surgery and hospitalization will be carried out during Experiment 2. The second metabolic study, however, will last only 1 hour and will include a standard clinical meal.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Care Provider)|
|Official Title:||Restoration of Muscle Following Hip Surgery|
|Study Start Date :||October 2006|
|Actual Primary Completion Date :||October 2012|
|Actual Study Completion Date :||October 2012|
|Experimental: Experiment 2 - Experimental Group||
200mg ketoconazole twice daily; started night before surgery and continued through hospitalization.
|No Intervention: Experiment 1 - Standard of care Group|
|Experimental: Experiment 1 - Experimental Group||
Drug: Essential amino acid supplement
15g of essential amino acid in capsule form three times daily during hospitalization, continued through 6 weeks after discharge.
|Placebo Comparator: Experiment 2 - Placebo Group||
Placebo for Ketoconazole
- Muscle Protein Synthesis [ Time Frame: Perioperative and discharge ]
- Change in Maximal Voluntary Contraction [ Time Frame: Baseline and 6 weeks post surgery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00393848
|United States, Arkansas|
|University of Arkansas for Medical Sciences|
|Little Rock, Arkansas, United States, 72205|
|Principal Investigator:||Arny Ferrando, PhD||University of Arkansas|